Cardiovascular consequences of sleep apnea: Ii-cardiovascular mechanisms;Uyku apnesinin kardiyovasküler sonuçlari: II-Kardiyovasküler mekanizmalar

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 2, 2010, Pages 168-175

  Çelen, Yelda Turgut ^a   Peker, Yüksel ^a,b  

^a Skaraborg Hospital   (Turkey)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cardiovascular diseases; Obstructive sleep apnea

Indexed keywords

LEPTIN;

ADRENERGIC ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHEYNE STOKES BREATHING; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; GLUCOSE INTOLERANCE; HEART ARRHYTHMIA; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; SLEEP APNEA SYNDROME; THORAX PRESSURE; CARDIOVASCULAR FUNCTION; GENOTYPE; HEMODYNAMICS; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; RISK FACTOR;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; GENOTYPE; HEMODYNAMICS; HUMANS; PHENOTYPE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 77952510137     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2010.044     Document Type: Article

References (60)

1. Turgut Celen Y, Peker Y. Cardiovascular consequences of sleep apnea: I- Epidemiology. Anadolu Kardiyol Derg 2010; 10: 75-80.
2. Fletcher EC. Effect of episodic hypoxia on sympathetic activity and blood pressure. Respir Physiol 2000; 119: 189-97.
3. Somers VK, Mark AL, Abboud FM. Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertens 1988; 11: 608-12.
4. Morgan BJ, Denahan T, Ebert TJ. Neurocirculatory consequences of negative intrathoracic pressure vs asphyxia during voluntary apnea. J Appl Physiol 1993; 74: 2969-75.
5. Shiomi T, Guilleminault C, Stoohs R, Schnittger I. Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome. Chest 1991; 100: 894-902.
6. Arias MA, Garcí-Río F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005; 112: 375-83.
7. Bradley TD. Right and left ventricular functional impairment and sleep apnea. Clin Chest Med 1992; 13: 459-79.
8. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-904.
9. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103: 1763-8.
10. Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98: 1071-7.
11. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98: 772-6.
12. Christou K, Kostikas K, Pastaka C, Tanou K, Antoniadou I, Gourgoulianis KI. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med 2009; 10: 87-94.
13. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14719 initially healthy American women. Circulation 2003; 107: 391-7.
14. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109: II2-II10.
15. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129-34.
16. Tazaki T, Minoguchi K, Yokoe T, Samson KT, Minoguchi H, Tanaka A, et al. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 170: 1354-9.
17. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999; 87: 10-4.
18. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
19. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149-53.
20. Drummond M, Winck J, Guimarães J, Santos AC, Almeida J, Marques J. Long- term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome. Arch Bronconeumol 2009; 45: 577-84.
21. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 1999; 31: 23-7.
22. Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 2001; 119: 1085-91.
23. Bayram NA, Çiftçi B, Keleş T, Durmaz T, Turhan S, Bozkurt E, et al. Endothelial function in normotensive men with obstructive sleep apnea before and 6 months after CPAP treatment. Sleep 2009; 32: 1257-63.
24. Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 2004; 169: 354-60.
25. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607-10.
26. Cross MD, Mills NL, Al-Abri M, Riha R, Vennelle M, Mackay TW, et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnea/hypopnea syndrome: a randomized controlled trial. Thorax 2008; 63: 578-83.
27. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure. Possible involvement of nitric oxide and asymmetric NG, NG Dimethylarginine. Circ J 2005;69: 221-6.
28. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999; 17: 61-6.
29. Eisensehr I, Ehrenberg BL, Noachtar S, Korbett K, Byrne A, Mcauley A, et al. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 1998; 51: 188-95.
30. Steiner S, Jax T, Evers S, Hennersdorf M, Schwalen A, Strauer BE. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 2005; 104: 92-6.
31. Hoffstein V, Herridge M, Mateika S, Redline S, Strohl KP. Hematocrit levels in sleep apnea. Chest 1994; 106: 787-91.
32. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. Circulating cardiovascular risk factors in obstructive sleep apnoea: Data from randomized controlled trials. Thorax 2004; 59: 777-82.
33. Hui DS, Ko FW, Fok JP, Chan MC, Li TS, Tomlinson B, et al. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 2004; 125: 1768-75.
34. Shitrit D, Peled N, Shitrit AB, Meidan S, Bendayan D, Sahar G, et al. An association between oxygen desaturation and D-dimer in patients with obstructive sleep apnea syndrome. Thromb Haemost 2005; 94: 544-7.
35. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000; 279: 234-7.
36. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight Men. Am J Respir Crit Care Med 2002; 165: 677-82.
37. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Collins B, Basta M, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 2008; 38: 585-95.
38. Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ. Sleepdisordered breathing and type 2 diabetes. A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008; 81: 2-12.
39. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Rook S, Schweiger U, et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004; 169: 1231-7.
40. Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, Schwartz AR, et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003; 552: 253-64.
41. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001; 104: 3052-6.
42. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115: 459-67.
43. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172: 625-30.
44. Baguet JP, Hammer L, Levy P, Pierre H, Launois S, Mallion JMv, et al. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 2005; 128: 3407-12.
45. Hedner J, Franklin K, Peker Y. Obstructive sleep apnea and coronary artery disease. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 4th ed. Philadelphia, PA: Elsevier Inc; 2005; p.1203-7.
46. Alonso-Fernandez A, Garcia-Rio F, Racionero MA, Pino JM, Ortuño F, Martínez I, et al. Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep-apneahypopnea syndrome and its mechanisms. Chest 2005; 127: 15-22.
47. Sorajja D, Gami AS, Somers VK, Behrenbeck TR, Garcia-Touchard A, Lopez-Jimenez F. Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 2008; 133: 927-33.
48. Turmel J, Sériès F, Boulet LP, Poirier P, Tardif JC, Rodés-Cabeau J, et al. Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. Int J Cardiol 2009; 132: 203-9.
49. Brodsky M, Wu D, Denes P, Kanakis C, Rosen KM. Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol 1977; 39: 390-5.
50. Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007; 49: 565-71.
51. Shepard JW, Garrison MW, Grither DA, Dolan GF. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 1985; 88: 335-40.
52. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 2000; 35: 569-82.
53. Cloward TV, Walker JM, Farney RJ, Anderson JL. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003; 124: 594-601.
54. Fung JW, Li TS, Choy DK, Yip GW, Ko FW, Sanderson JE, et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest 2002; 121: 422-9.
55. Tuǧcu A, Güzel D, Yildirimtürk O, Aytekin S. Evaluation of right ventricular systolic and diastolic function in patients with newly diagnosed obstructive sleep apnea syndrome without hypertension. Cardiology 2009; 113: 184-92.
56. Mansfield DR, Solin P, Roebuck T, Bergin P, Kaye DM, Naughton MT. The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest 2003; 124: 1675-81.
57. Bradley TD, Floras JS. Sleep apnea and heart failure: Part II: Central sleep apnea. Circulation 2003; 107: 1822-6.
58. Yumino D, Bradley TD. Central Sleep Apnea and Cheyne-Stokes Respiration. Proc Am Thorac Soc 2008; 5: 226-36.
59. Hanly P, Zuberi N, Gray R. Pathogenesis of Cheyne-Stokes respiration in patients with congestive heart failure: Relationship to arterial PCO2. Chest 1993; 104: 1079-84.
60. Bradley TD, Phillipson EA. Central sleep apnea. Clin Chest Med 1992; 13: 493-505.